AINDEX
Markets

Aclarion, Inc. (ACONW)

ACONWNASDAQ-CMMedical Specialities

$0.0214

0.0000 (0.00%) today

Regular session, Nov 13, 3:59 PM ET

– 1D
Market cap
$61.7k
P/E
–
EPS, last 4 quarters
–
Dividend yield
–
Day range
–
52-week range
$0.0200 to $0.1990
Average volume
–
Previous close
$0.0214

Financials

QuarterDec 2025Mar 2026Jun 2026Sep 2026
Revenue$18.0k$21.0k$25.0k$34.0k
Gross profit$2,000$4,000$8,000$15.0k
Operating income-$1.99m-$2.99m-$2.90m-$2.75m
Net income-$1.89m-$2.85m-$2.75m-$2.62m

Last four quarters: revenue $98.0k, margin -10319.4%, free cash flow –

News

8 latest

The company

Aclarion is a healthcare technology company that leverages Magnetic Resonance Spectroscopy ('MRS'), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan, the first, evidence-supported, SaaS platform to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. Biomarker data is entered into proprietary algorithms to indicate if a disc may be a source of pain.

Sector
Health Care
Industry
Medical Specialities
Exchange
NASDAQ-CM
Region
North America

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.